(CLVT) CLARIVATE - Ratings and Ratios

Clarivate Plc (NYSE:CLVT) is a leading global provider of information services, operating across the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company is structured into three core segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. This strategic segmentation allows Clarivate to cater to diverse needs, from academic research to intellectual property management.

The company offers a suite of products that facilitate research and innovation. Web of Science and InCites are pivotal tools for analyzing academic research landscapes and managing research information, while ProQuest One and Ebook Central provide cost-effective access to comprehensive content collections for institutions. Alma and Polaris serve to manage academic resources and support research publications, enhancing connectivity and efficiency for users.

In the Intellectual Property segment, Clarivate provides essential services such as Patent and Trademark Renewals, which streamline administrative tasks. CompuMark and Derwent offer critical support for decisions around patent and trademark protection, risk management, and value creation. Additionally, IPFolio and Foundation IP create structured environments for managing global patent and trademark assets, ensuring comprehensive protection and strategy execution.

Clarivate also plays a significant role in the Life Sciences & Healthcare sector with Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, which support drug and medical device development from discovery to clinical trials. Cortellis Regulatory Intelligence and OFF-X help monitor drug safety and adhere to regulatory protocols, while Real World Data and Optimize inform commercial strategies and pricing for optimal reimbursement.

With a diverse clientele including corporations, universities, law firms, government agencies, and professional services organizations, Clarivates reach is extensive. The companys heritage dates back to 1864, with a rebranding from Clarivate Analytics to Clarivate Plc in 2020, reflecting its evolution and commitment to innovation. Headquartered in London, Clarivate continues to be a trusted partner in advancing knowledge and innovation globally.

Financially, Clarivate presents a market capitalization of approximately $3.587 billion, with a forward P/E ratio of 7.06, indicating expectations for future earnings growth. The price-to-sales ratio of 1.39 reflects its revenue generation efficiency, while the price-to-book ratio of 0.65 suggests a potential undervaluation relative to its assets. These metrics provide insights for investors and fund managers evaluating Clarivates investment potential, highlighting its role in high-growth sectors with strong demand for data-driven decision-making tools.